← All stocks

UroGen Pharma Ltd.

URGN Net selling
CIK 0001668243 #1945 in the set updated 17 Sep 2026
Bought (120 mo)
$791.52K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$15.54M
$1.30M on a plan · $1.46M straight out of an exercise
Sold at will
$12.77M
31 of 94 sales
Net
−$14.74M
−$11.98M against sales at will

By person

17 insiders · 114 transactions
16.2×

Elizabeth Barrett holds 16.2 times base salary in stock. $13.90M of shares against $855.59K in salary for 2025.

Salary from the company's own proxy. The shares are what Elizabeth Barrett last reported holding, valued at $42.54, the price Ordinary Shares was last bought or sold at on the open market here, on 8 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
ProQuest Investments IV, L.P. entity
10% owner
$8.50M (2)
−$8.50M
1,242,031
$52.84M
−14.4%
Schoenberg Mark
Chief Medical Officer
$67.38K (3)
$5.38M (49)
−$5.31M
67,849
$2.89M
+217.5%
Smith Jason Drew
General Counsel
$39.28K (1)
$725.47K (19) scheduled
−$686.19K
53,141
$2.26M
Mullennix Stephen
Chief Operating Officer
$203.44K (7) scheduled
−$203.44K
10,084
$428.97K
PFREUNDSCHUH PETER P.
Chief Financial Officer
$166.69K (11) scheduled
−$166.69K
10,405
$442.63K
+940.5%
Barrett Elizabeth A.
Chief Executive Officer
$645.25K (4)
$491.88K (3)
+$153.37K
326,691
$13.90M
Degnan Chris
Chief Financial Officer
$37.12K (1) scheduled
−$37.12K
2,280
$96.99K
Henderson Molly
Chief Financial Officer
$39.63K (1)
$33.63K (2) scheduled
+$5.99K
5,248
$223.25K
Nussbaum Ran
Director
4,381,054
$186.37M
+1.3%
Belldegrun Arie
Director
408,693
$17.39M
+257.8%
Cohen Fred E
Director
84,339
$3.59M
Kim Dong
Chief Financial Officer
37,753
$1.61M
+18.3%
Robinson James A. Jr.
Director
8,000
$340.32K
WEN LEANA
Director
2,000
$85.08K
Wildman Daniel George
Director
2,000
$85.08K
Holden Stuart
Director
2,000
$85.08K
BUTITTA CYNTHIA M
Director
2,000
$85.08K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Schoenberg Mark
18 Nov 2021
Chief Medical Officer
Buy
160
$13.10
$2.10K
Smith Jason Drew
17 May 2021
General Counsel
Buy
2,500
$15.71
$39.28K
Henderson Molly
17 May 2021
Chief Financial Officer
Buy
2,500
$15.85
$39.63K
Barrett Elizabeth A.
14 Dec 2020
Chief Executive Officer
Buy
10,000
$18.50
$185.00K
Barrett Elizabeth A.
21 Nov 2019
Chief Executive Officer
Buy
7,530
$28.00
$210.84K
Barrett Elizabeth A.
20 Nov 2019
Chief Executive Officer
Buy
7,470
$28.00
$209.16K
Schoenberg Mark
19 Nov 2019
Chief Medical Officer
Buy indirect
1,960
$28.17
$55.21K
Barrett Elizabeth A.
15 Nov 2019
Chief Executive Officer
Buy
1,548
$26.00
$40.25K
Schoenberg Mark
21 Mar 2019
Chief Medical Officer
Buy
272
$37.01
$10.07K

What was left out

Form 4 filings counted 195
Amendments (4/A) skipped 12
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 59
Sales at will 31
Transactions with no price 0
Shares from compensation/vesting 1,174,051
Sales filed before the plan box existed 17
History held since 29 Nov 2017